Works by Berenbaum, Arnaud

Results: 5
    1
    2

    [18F]FDG PET/CT for predicting triple-negative breast cancer outcomes after neoadjuvant chemotherapy with or without pembrolizumab.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 13, p. 4024, doi. 10.1007/s00259-023-06394-y
    By:
    • Seban, Romain-David;
    • Arnaud, Emilie;
    • Loirat, Delphine;
    • Cabel, Luc;
    • Cottu, Paul;
    • Djerroudi, Lounes;
    • Hescot, Segolene;
    • Loap, Pierre;
    • Bonneau, Claire;
    • Bidard, Francois-Clement;
    • Huchet, Virginie;
    • Jehanno, Nina;
    • Berenbaum, Arnaud;
    • Champion, Laurence;
    • Buvat, Irene
    Publication type:
    Article
    3

    Baseline metabolic tumor burden on FDG PET/CT scans predicts outcome in advanced NSCLC patients treated with immune checkpoint inhibitors.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2020, v. 47, n. 5, p. 1147, doi. 10.1007/s00259-019-04615-x
    By:
    • Seban, Romain-David;
    • Mezquita, Laura;
    • Berenbaum, Arnaud;
    • Dercle, Laurent;
    • Botticella, Angela;
    • Le Pechoux, Cécile;
    • Caramella, Caroline;
    • Deutsch, Eric;
    • Grimaldi, Serena;
    • Adam, Julien;
    • Ammari, Samy;
    • Planchard, David;
    • Leboulleux, Sophie;
    • Besse, Benjamin
    Publication type:
    Article
    4

    Ultra-low-dose in brain 18F-FDG PET/MRI in clinical settings.

    Published in:
    Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-18029-7
    By:
    • Soret, Marine;
    • Maisonobe, Jacques-Antoine;
    • Desarnaud, Serge;
    • Bergeret, Sébastien;
    • Causse-Lemercier, Valérie;
    • Berenbaum, Arnaud;
    • Rozenblum, Laura;
    • Habert, Marie-Odile;
    • Kas, Aurélie
    Publication type:
    Article
    5